Ethyl 2-(2-(4-chlorophenyl)thiazol-4-yl)acetate

Catalog No. :
ACJANK963
CAS No. :
20287-70-1
Molecular Formula :
C13H12ClNO2S
Molecular Weight :
281.76

IUPAC Name:ethyl 2-(2-(4-chlorophenyl)thiazol-4-yl)acetate

Ethyl 2-(2-(4-chlorophenyl)thiazol-4-yl)acetate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$264.00Login to see priceIn stockInquiry
250mg95%$442.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 2-(2-(4-chlorophenyl)thiazol-4-yl)acetate
IUPAC Nameethyl 2-(2-(4-chlorophenyl)thiazol-4-yl)acetate
MDL No.MFCD01765002
Molecular FormulaC13H12ClNO2S
Molecular Weight281.76
SMILESO=C(OCC)CC1=CSC(C2=CC=C(Cl)C=C2)=N1
InChI KeyVTDNBASRFGRNAV-UHFFFAOYSA-N
SynonymEthyl 2-(2-(4-chlorophenyl)thiazol-4-yl)acetate | 20287-70-1 | ethyl 2-[2-(4-chlorophenyl)-1,3-thiazol-4-yl]acetate | 2-(4-Chlorophenyl)-4-thiazoleacetic acid ethyl ester | Ethyl fenclozic acid | 4-Thiazoleacetic acid, 2-(4-chlorophenyl)-, ethyl ester | [2-(4-Chloro-
CAS No.20287-70-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACJANK963 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACNZYM496 route compound structure diagram
    ACNZYM4962521-24-6 In Stock
  4. Then
  5. ACJANK963 route product structure diagram
    ACJANK96320287-70-1 In Stock
Inquiry

2. ACJANK963 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACUXNE651 route compound structure diagram
    ACUXNE65113176-46-0 In Stock
  2. Plus
  3. ACNZYM496 route compound structure diagram
    ACNZYM4962521-24-6 In Stock
  4. Then
  5. ACJANK963 route product structure diagram
    ACJANK96320287-70-1 In Stock
Inquiry

Comments (0)